STAT Wunderkind Kristine Chua's research on microchimerism has the potential to ...
Just in time for cold and flu season, the FDA says a popular decongestant is no ...
Private equity's less than stellar track record as owners of health systems rais...
How the government can help lower the price — not just the cost — of cutting-edg...
Nearly six weeks after his surgery, the world’s second recipient of a geneticall...
An advocacy group argues that Medicare should factor in controversial patent man...
AlphaFold can now predict what proteins look like in combination with several cl...
Actions taken by federal agencies in response to President Biden’s executive ord...
La "paradoja hispana" intriga a una nueva generación de investigadores decididos...
Want to stay on top of the science and politics driving biotech today? Sign up t...
Sarepta said its gene therapy for Duchenne muscular dystrophy failed to improve ...
The US Food and Drug Administration (FDA) has accepted Day One Biopharmaceutica...
Shorla Oncology has acquired the oncology and autoimmune drug Jylamvo (methotre...
SpyGlass Pharma is initiating Phase I/II clinical trials investigating its drug...
The third quarter of 2023 saw a slight fall in deal activity after the recovery ...
Aragen Life Sciences has invested $30m to set up a new biologics manufactur...
